Zevra Denmark Drug Patent Portfolio
Zevra Denmark owns 1 orange book drug protected by 3 US patents Given below is the list of Zevra Denmark's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11045460 | Use of Hsp70 as a regulator of enzymatic activity | 19 Aug, 2029 | Active |
| US9289472 | Use of HSP70 as a regulator of enzymatic activity | 11 Aug, 2029 | Active |
| US9884058 | Use of Hsp70 as a regulator of enzymatic activity | 26 Jun, 2029 | Active |
Zevra Denmark's Family Patents
Zevra Denmark Drug List
Given below is the complete list of Zevra Denmark's drugs and the patents protecting them.
1. Miplyffa
Miplyffa is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11045460 | Use of Hsp70 as a regulator of enzymatic activity |
19 Aug, 2029
(4 years from now)
| Active |
| US9289472 | Use of HSP70 as a regulator of enzymatic activity |
11 Aug, 2029
(4 years from now)
| Active |
| US9884058 | Use of Hsp70 as a regulator of enzymatic activity |
26 Jun, 2029
(4 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Miplyffa's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List